Bone-derived and recombinant transforming growth factor β′S are potent inhibitors of tumor cell growth
- 26 October 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 148 (2) , 783-789
- https://doi.org/10.1016/0006-291x(87)90944-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptorsCell, 1987
- Epithelial Wound Healing Enhanced by Transforming Growth Factor-α and Vaccinia Growth FactorScience, 1987
- Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from PlateletsScience, 1986
- Transforming Growth Factor-β: Biological Function and Chemical StructureScience, 1986
- Differentiation of rat mesenchymal cells by cartilage-inducing factorExperimental Cell Research, 1986
- Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth FactorScience, 1986
- Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-βNature, 1985
- Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth FactorScience, 1984
- Purification and properties of a type .beta. transforming growth factor from bovine kidneyBiochemistry, 1983